![]() |
![]() |
Legal status
Patent revoked (after opposition at EPO)
(51) | INT.CL. | A61K 38/00 | (2006.01) |
A61K 38/28 | (2006.01) | ||
A61K 9/26 | (2006.01) | ||
A61K 33/06 | (2006.01) | ||
A61P 25/28 | (2006.01) |
(11) | Number of the document | 1033996 |
(13) | Kind of document | T |
(96) | European patent application number | 98961833.5 |
Date of filing the European patent application | 1998-11-30 | |
(97) | Date of publication of the European application | 2000-09-13 |
(45) | Date of publication and mention of the grant of the patent | 2008-06-25 |
(46) | Date of publication of the claims translation | 2008-11-25 |
(86) | Number | PCT/US1998/025386 |
Date | 1998-11-30 |
(87) | Number | WO 1999/027944 |
Date | 1999-06-10 |
(30) | Number | Date | Country code |
67740 P | 1997-12-02 | US | |
80970 P | 1998-04-07 | US |
(72) |
SCHENK, Dale, B., US
|
(73) |
Janssen Alzheimer Immunotherapy,
Little Island Industrial Estate, Little Island, County Cork,
IE
|
(74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Amiloidogeninės ligos prevencija ir gydymas |
PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE |
Payment date | Validity (years) | Amount | |
2016-10-19 | 19 | 347.00 EUR |
Patent revoked (after opposition at EPO) | ||
Invalidation date | 2017-07-03 |